Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Ironwood Pharmaceuticals, Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
IRWD
Nasdaq
8731
https://www.ironwoodpharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
- Apr 25th, 2024 8:01 pm
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
- Mar 25th, 2024 1:57 pm
It’s Time! 3 Failing Biotech Stocks to Sell Right Now
- Mar 5th, 2024 6:05 pm
Ironwood Pharmaceuticals Ran Up 38% Over Three Months — And Just Lost It All
- Feb 29th, 2024 9:19 pm
Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
- Feb 29th, 2024 11:00 am
Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference
- Feb 23rd, 2024 12:30 pm
Ironwood Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations
- Feb 17th, 2024 12:50 pm
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript
- Feb 16th, 2024 3:15 pm
Ironwood (IRWD) Q4 Earnings Miss, Revenues Beat Marginally
- Feb 16th, 2024 2:36 pm
Q4 2023 Ironwood Pharmaceuticals Inc Earnings Call
- Feb 16th, 2024 3:45 am
Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q4
- Feb 15th, 2024 1:15 pm
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
- Feb 15th, 2024 12:00 pm
Ironwood (IRWD) is on the Move, Here's Why the Trend Could be Sustainable
- Feb 5th, 2024 1:50 pm
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Investor Update Call
- Feb 1st, 2024 9:01 pm
Wall Street Analysts Think Ironwood (IRWD) Could Surge 37.6%: Read This Before Placing a Bet
- Jan 23rd, 2024 2:55 pm
Ironwood Announces Publication in The Lancet Gastroenterology & Hepatology of New Linaclotide Phase III Data in Children and Adolescents Aged 6-17 Years with Functional Constipation
- Jan 9th, 2024 12:00 am
Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance
- Jan 8th, 2024 11:00 am
Ironwood Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 3rd, 2024 9:01 pm
Ironwood Announces the Completion of Squeeze-Out Merger With VectivBio
- Dec 12th, 2023 9:01 pm
Shareholders have faith in loss-making Ironwood Pharmaceuticals (NASDAQ:IRWD) as stock climbs 9.7% in past week, taking five-year gain to 2.3%
- Dec 5th, 2023 10:36 am
Scroll